Get to Know LL&M Winter Symposium

LL&M Winter Symposium bridges the gap between emerging data and real-world decision-making in hematologic malignancies. Through focused discussions, expert analysis, and case-based learning, the program goes beyond presenting new evidence—it translates it into clear, practical strategies you can apply in your practice immediately.

What You Need to Know

What-You-Need-to-Know

    • What is LL&M Winter Symposium?

      LL&M Winter Symposium is an early-year hematology meeting designed to bring clinicians up to speed on the latest advances in blood cancers — including leukemia, lymphoma, myeloma, and CLL — by translating new scientific evidence into practical, real-world clinical strategies. The program emphasizes data-driven presentations, expert-led case studies, and interactive Q&A, enabling attendees to understand how emerging research impacts patient care and clinical decision-making.

    • Who should attend LL&M Winter Symposium?

      This event is intended for the full hematology/oncology care team: physicians, advanced practice providers, pharmacists, nurses, researchers, trainees, and other allied health professionals involved in managing hematologic malignancies. Whether you focus on leukemia, lymphoma, myeloma, or CLL, the Symposium offers clinically relevant updates that support everyday patient management and care optimization.

    • How does LL&M Winter Symposium connect with LL&M Congress?

      LL&M Winter Symposium complements the flagship LL&M Congress by extending the 25+ year tradition of high-quality hematology education into the new year. While the Congress provides a broad, multi-day, in-depth review across hematologic malignancies each fall, the Winter Symposium offers a concentrated, early-year program focused on quickly integrating the most recent global research and clinical trial data into practice. Together, they form a year-round educational continuum for hematology professionals.

    • Is the LL&M Winter Symposium focused on real-world clinical practice?

      Yes. The program is built around case-based discussions, expert perspectives, and practical insights that reflect real-world patient scenarios, making it highly relevant for everyday clinical decision-making.

    • What will I gain from attending the LL&M Winter Symposium?

      Attendees gain a clearer understanding of new and emerging data, along with practical strategies for applying that information in clinical practice. The focus is on improving confidence in treatment decisions and patient management.

    • Who are the faculty at the LL&M Winter Symposium?

      The program features leading experts in hematologic malignancies who are actively involved in research, clinical care, and guideline development.

How Do We Compare?

Key Features

LL&M Winter Symposium

Compared to Other Hematology Meetings

Scope of Curriculum Presents the latest clinical advances in hematologic malignancies (leukemia, lymphoma, myeloma, and CLL) with a focus on synthesizing breaking data and incorporating it into practice. Many meetings focus primarily on updates or single disease areas without the aggressive emphasis on data-to-practice translation.
Educational Format Combines data-driven presentations, expert-led case studies, interactive Q&A sessions, and networking opportunities to embed insights into clinical workflows. Other conferences may be more traditional and lecture-centric, with less emphasis on immediate translation or interactive elements.
Faculty Expertise Features a broad roster of leading clinical investigators and practicing hematology/oncology specialists whose work spans multiple malignancies and emerging therapies. Some meetings may have narrower faculty composition (for example, disease-specific or research-only) and less breadth of practical clinical leadership.
Timing & Positioning Serves as an early-year symposium, positioning attendees ahead of the annual conference cycle with up-to-date data and key strategies for the year ahead. Many hematology meetings are standalone and may occur later in the year, so insights are not always positioned as the first major update of the year.
Audience Engagement & Networking Provides a focused, immersive environment with ample opportunities for peer interaction, networking, and reflection on practice. Other meetings often take place in more standard conference settings with fewer curated networking opportunities.
Practical Takeaways & Integration Designed to leave attendees with actionable, clinically relevant strategies: how to interpret trial data, integrate novel agents, and adapt to evolving standards of care. Many meetings provide high-level data overview but offer less focused guidance on implementation in daily practice.
Continuity & Educational Ecosystem Builds on the legacy of LL&M while complementing the flagship Congress and related programs, offering a continuum of hematology education. Some conferences operate in isolation without explicit links to a broader educational ecosystem.
Back to top